Study #2023-0398
A phase 1b-2, multicenter, trial to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of Rec-4881 in patients with familial Adenomatous Polyposis (Fap)
MD Anderson Study Status
Enrolling
Treatment Agent
Placebo, REC-4881
Description
This is a multicenter, two-part trial in participants with Familial Adenomatous Polyposis (FAP).
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Familial Adenomatous Polyposis
Study phase:
Physician name:
Eduardo Vilar Sanchez
Department:
Clinical Cancer Prevention
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Your gift will help make a tremendous difference.
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.